Royalty Pharma plc 4

Christopher Hite sold 100,000 Class A Ordinary Shares of Royalty Pharma plc for roughly $6.0 million and gifted 16,800 shares to charity.

On August 18, 2026, Christopher Hite, EVP & Chairman, Partnering of Royalty Pharma plc, sold 100,000 Class A Ordinary Shares at a weighted average price of approximately $59.97 per share for total proceeds of about $5.997 million through SCH Investment Partners LLC under a pre-arranged Rule 10b5‑1 trading plan, reducing that indirect position to 370,401 shares. On August 19, 2026, he also made a charitable gift of 16,800 Class A Ordinary Shares to Lehigh University, leaving him with 23,200 Class A Ordinary Shares held directly. In addition to these holdings, family vehicles controlled by Hite retain significant economic exposure via interests exchangeable into more than 2.1 million additional Class A Ordinary Shares, some of which are subject to vesting conditions.

Filing Facts

CIK

1802768

Ticker

RPRX

Form

4

Source Type

fda

Accession

0001814238-26-000015

Alert Tier

7